These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 17549437

  • 1. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
    Kovac M, Mikovic D, Antonijevic N, Rakicevic L, Djordjevic V, Radojkovic D, Elezovic I.
    J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
    [Abstract] [Full Text] [Related]

  • 2. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 3. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J, Ormsby WD, Ashrani AA, McBane RD, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA.
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [Abstract] [Full Text] [Related]

  • 4. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
    Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.
    Arch Intern Med; 2002 Nov 11; 162(20):2357-60. PubMed ID: 12418950
    [Abstract] [Full Text] [Related]

  • 5. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M, Limacher A, Stalder O, Angelillo-Scherrer A, Alberio L, Fontana P, Beer HJ, Rodondi N, Lämmle B, Aujesky D.
    Am J Med; 2017 Oct 11; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [Abstract] [Full Text] [Related]

  • 6. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K, Svensson PJ, Ohlin AK.
    Thromb Res; 2007 Oct 11; 121(2):145-51. PubMed ID: 17499343
    [Abstract] [Full Text] [Related]

  • 7. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I, Battaglioli T, Razzari C, Mannucci PM.
    J Thromb Haemost; 2007 Jan 11; 5(1):98-101. PubMed ID: 17067362
    [Abstract] [Full Text] [Related]

  • 8. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2005 Jun 11; 19(3):189-96. PubMed ID: 16082606
    [Abstract] [Full Text] [Related]

  • 9. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
    Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, Di Minno G.
    Chest; 2000 Nov 11; 118(5):1405-11. PubMed ID: 11083693
    [Abstract] [Full Text] [Related]

  • 10. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
    Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Br J Haematol; 2002 Mar 11; 116(3):625-31. PubMed ID: 11849222
    [Abstract] [Full Text] [Related]

  • 11. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF, Wiewel-Verschueren S, Monster TB, Meijer K.
    J Thromb Haemost; 2016 Jul 11; 14(7):1393-403. PubMed ID: 27121914
    [Abstract] [Full Text] [Related]

  • 12. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M, Registro Informatizado de Enfermedad TromboEmbólica Investigators.
    Am J Med; 2017 Apr 11; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [Abstract] [Full Text] [Related]

  • 13. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA.
    Thromb Haemost; 1997 Apr 11; 77(4):624-8. PubMed ID: 9134632
    [Abstract] [Full Text] [Related]

  • 14. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N, Tamim H, Elias G, Choueiry S, Kreidy R, Daccache JL, Almawi WY.
    J Thromb Thrombolysis; 2001 Apr 11; 11(2):111-6. PubMed ID: 11406725
    [Abstract] [Full Text] [Related]

  • 15. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.
    Clin Appl Thromb Hemost; 2010 Feb 11; 16(1):66-70. PubMed ID: 18796457
    [Abstract] [Full Text] [Related]

  • 16. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
    Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, Di Minno G.
    Thromb Haemost; 1999 Dec 11; 82(6):1583-7. PubMed ID: 10613638
    [Abstract] [Full Text] [Related]

  • 17. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A, Mosena L, Prins MH, Prandoni P.
    Haematologica; 2007 Aug 11; 92(8):1107-14. PubMed ID: 17650440
    [Abstract] [Full Text] [Related]

  • 18. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM.
    J Am Coll Cardiol; 2001 Jan 11; 37(1):215-8. PubMed ID: 11153741
    [Abstract] [Full Text] [Related]

  • 19. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L, Schindewolf M, Schwonberg J, Hecking C, Wolf Z, Erbe M, Lindhoff-Last E, Linnemann B.
    Vasa; 2015 Jul 11; 44(4):313-23. PubMed ID: 26314364
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
    Shafia S, Zargar MH, Khan N, Ahmad R, Shah ZA, Asimi R.
    Gene; 2018 May 15; 654():1-9. PubMed ID: 29454086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.